Pneumonia Caused by Fungal Infection in Dogs (Mycotic Pneumonia)

  • Occurrence: rarer
  • Location of disease: Chest
Author: Dr. med. vet. Gisa Löwe | Last modified: 08.08.2026
Open table of contents

When to visit the vet?

Urgent see a veterinarian within 24 hours

?

If the condition worsens / symptoms persist, consult a veterinarian.

Download/Print

Definition

Mycotic pneumonia in dogs is an inflammatory disease of the lungs caused by a fungal infection. This type of Pneumonia can be caused by various fungal species and typically affects dogs living in certain geographical regions or raised under specific living conditions.

Das Wichtigste auf einen Blick

Mycotic pneumonia in dogs is caused by inhaling fungal spores that settle in the lungs and can cause an infection. Fungi of the genera Aspergillus, Histoplasma, Blastomyces, and Coccidioides are commonly involved and can be found in soil, decaying plant material, or animal droppings. A weakened immune system or living in areas with a high prevalence of fungi increases the risk of infection. Symptoms include Respiratory distress, Cough, apathy, and Fever. Diagnosis is made through clinical examinations, blood tests, and imaging procedures such as X-ray or CT. Treatment consists of antimycotic medications such as itraconazole, ketoconazole, or fluconazole and can take several months. Supportive therapy may be required. The prognosis depends on the severity of the infection and timely treatment. Preventive measures include reducing exposure to fungal spores by avoiding known fungal sources, as well as regular veterinary examinations. Research focuses on identifying specific fungal species, developing improved diagnostic methods, and creating new, safer antifungals. Genetic predisposition and the role of the immune system are also being investigated to develop better prevention and treatment strategies.

Ursachen

Fungi are a diverse group of microorganisms that are widespread in the environment. They can be both beneficial and harmful. While many fungi are harmless, there are some that can cause diseases in animals and humans. Fungal pneumonia occurs when a dog inhales fungal spores, which then settle in the lungs and cause an infection.

The most common fungi that cause mycotic pneumonia in dogs belong to the genera Aspergillus, Histoplasma, Blastomyces, and Coccidioides. These fungi can be found in soil, decaying plant material, or in bird and bat droppings. The likelihood of an infection depends on the type of fungus, the living conditions, and the dog’s immune system.

A weakened immune system, whether due to illness, age, or genetic predisposition, can increase the risk of a fungal infection. Dogs living in areas with a high prevalence of fungi or those spending a lot of time outdoors are also at increased risk. Climatic conditions such as humidity and warmth promote fungal growth and thus the spread of fungal spores in the air.

Symptoms

Rare symptoms:

Symptoms of mycotic pneumonia in dogs can vary depending on the severity of the infection and the fungal species involved. The most common symptoms include Cough, Respiratory distress, fatigue, and loss of appetite. In severe cases, Fever, Weight loss, and a general deterioration in health can occur.

A persistent or productive cough that does not respond to standard treatment may indicate a fungal infection. Nasal discharge and Skin lesions are also possible signs, especially if the infection spreads beyond the lungs. In advanced disease, neurological symptoms such as Convulsions may occur if the fungi reach the central nervous system (CNS).

Diagnose

Diagnosis of mycotic pneumonia usually begins with a thorough clinical examination and taking the dog’s medical history, including its living conditions and previous diseases. Blood tests can provide indications of an infection, especially if certain inflammatory markers are elevated.

Chest X-rays can show changes in lung structure that indicate a fungal infection. In some cases, CT scans may also be required to obtain a more detailed picture of the lung changes. A definitive diagnosis is often made by detecting the fungus in a lung biopsy or fungal antigens in body fluids.

Therapie

Treatment of mycotic pneumonia in dogs usually consists of administering antifungals aimed at killing the fungus or inhibiting its growth. The choice of medication depends on the type of fungal infestation causing it. Commonly used medications include itraconazole, ketoconazole, and fluconazole.

Treatment can last several months, especially in cases of severe infections. In some cases, supportive therapy may also be required, such as oxygen supply for severe Respiratory distress or the treatment of secondary infections with antibiotics. Strict adherence to the treatment plan and regular veterinary check-ups are crucial for the success of the therapy.

Prognose und Nachsorge

The prognosis for mycotic pneumonia in dogs depends on various factors, including the severity of the infection, the fungal species, and timely and appropriate treatment. In many cases, early diagnosis and treatment can lead to a full recovery.

In advanced or complex cases, however, the prognosis may be guarded. Factors such as the dog’s age, overall health, and response to treatment also play a role. Long-term follow-up checks are important to prevent the infection from recurring.

Prävention

Prevention of mycotic pneumonia in dogs includes measures to reduce exposure to fungal spores. This includes keeping dogs away from known fungal sources, such as areas with decaying plant material or animal droppings.

Regular veterinary examinations and good general preventive care can help strengthen the dog’s immune system and reduce the risk of infection. In areas with a high prevalence of fungi, it may be advisable to keep dogs indoors or monitor their time outdoors, especially after rainfall or during humid seasons.

Ausblick auf aktuelle Forschung

Mycotic pneumonia in dogs is a disease caused by inhaling fungal spores found in damp or wooded environments. These spores can enter the lungs and trigger inflammation. Current research approaches focus on identifying the different fungal species responsible for this disease, including Aspergillus, Histoplasma, and Blastomyces. Scientists are working to understand the exact mechanisms by which these fungi trigger an infection in order to develop more targeted treatment methods.

Another interesting area of research is the development of improved diagnostic methods. Currently, many diagnoses are based on clinical symptoms and X-ray images / radiographs, but researchers are looking for more specific and faster tests to confirm the diagnosis of fungal lung infections. Molecular techniques such as polymerase chain reaction (PCR) are being investigated to improve their use in clinical practice.

Furthermore, great emphasis is being placed on developing newer, safer, and more effective antifungals. Many of the medications currently available have side effects that can be problematic in dogs. Researchers are striving to develop drugs that target fungal cells without damaging the animal’s healthy cells. In this context, natural substances that may have antimycotic properties are also being investigated.

Another research focus is the prevention of mycotic pneumonia. Since dogs become infected by inhaling spores, research is examining how exposure to these spores can be minimized. This includes investigating environmental factors that promote fungal growth, as well as developing vaccines that could strengthen the dog’s immune system to fend off infections.

Genetic predisposition in dogs to fungal infections is another area receiving attention. Some breeds appear to be more susceptible to mycotic pneumonia, and researchers are currently identifying genetic markers associated with an increased risk. This knowledge could help with breeding planning in the future to reduce the risk of fungal infections.

Finally, the role of the immune system in the development of mycotic pneumonia is also being investigated. Researchers are trying to understand why some dogs are more susceptible to infections than others and how the immune system can be modulated so it is better prepared to deal with fungal infestation. This research could lead to new therapeutic approaches that not only treat the fungal infections themselves but also strengthen the dog’s immune system.

Frequently Asked Questions (FAQs)

1. What are the most common symptoms of mycotic pneumonia in dogs?
The most common symptoms of fungal pneumonia in dogs are Cough, shortness of breath, Weight loss, Fever, and lethargy. In some cases, loss of appetite may also be observed. These symptoms can develop slowly and are often difficult to distinguish from other respiratory diseases.
2. How is mycotic pneumonia in dogs diagnosed?
The diagnosis of fungal pneumonia is typically made through a combination of clinical symptoms, chest X-rays, and laboratory tests that detect fungal spores or antibodies in the blood. In some cases, a bronchoscopy may also be performed to collect samples directly from the lungs.
3. What treatment options are available for dogs with mycotic pneumonia?
Treatment of fungal pneumonia typically involves administering antifungal medications that specifically target the causative fungal species. Treatment can last several weeks to months, and in some cases, additional medications are required to relieve symptoms or strengthen the immune system.
4. Can mycotic pneumonia in dogs be prevented?
Preventing fungal pneumonia is difficult since fungal spores are widespread. However, dog owners can take measures to minimize exposure, such as avoiding walks in damp, wooded areas, especially after rainfall. Regular health checkups can help detect infections early.
5. Are certain dog breeds more susceptible to mycotic pneumonia?
Yes, certain dog breeds appear to be more susceptible to fungal pneumonia, including large breeds such as the German Shepherd and Doberman. Dogs with weakened immune systems or pre-existing respiratory conditions are also often at greater risk.
6. Is mycotic pneumonia in dogs contagious to humans or other animals?
Typically, fungal pneumonia in dogs is not directly transmissible to humans or other animals. However, the same environmental conditions that promote infection in dogs can also pose a risk to humans or other animals, particularly for individuals with weakened immune systems.
7. How long does it take for a dog to recover from mycotic pneumonia?
Recovery time can vary depending on the severity of the infection and response to treatment. In mild cases, improvement may occur within weeks, while more severe cases may require several months of intensive treatment to heal completely.
8. Can mycotic pneumonia in dogs recur?
Yes, fungal pneumonia can recur in dogs, especially if the underlying cause of the infection has not been completely eliminated or if the dog is exposed to spores again. Continuous monitoring and retreatment when necessary are important to prevent relapses.
9. What complications can occur with mycotic pneumonia?
Possible complications of fungal pneumonia include chronic respiratory diseases, spread of the infection to other organs, and in the worst case, respiratory failure. Early diagnosis and treatment are crucial to avoid serious complications.
10. Can mycotic pneumonia in dogs be fatal?
Yes, if left untreated, severe fungal pneumonia can be fatal in dogs. Even with treatment, the risk of complications is high, especially in dogs with a weakened immune system or other health problems. Prompt diagnosis and a comprehensive treatment plan are crucial for recovery.

Literatur

  • Tarosky, M., Haraschak, J. L., Reinhart, J. M., & Billhymer, A. (2024). Case series of dogs with blastomycosis managed with high-flow nasal oxygen therapy (2019–2023): 19 cases. Frontiers in Veterinary Science, 11, Article 1369259. https://doi.org/10.3389/fvets.2024.1369259
  • Motschenbacher, L. O., Furrow, E., Rendahl, A. K., Nell, E. G., Anderson, K. L., Merkel, L. K., & Sykes, J. E. (2021). Retrospective analysis of the effects of Blastomyces antigen concentration in urine and radiographic findings on survival in dogs with blastomycosis. Journal of Veterinary Internal Medicine, 35(2), 946–953. https://doi.org/10.1111/jvim.16041
  • Crews, L. J., Feeney, D. A., Jessen, C. R., Newman, A. B., & Sharkey, L. C. (2008). Utility of diagnostic tests for and medical treatment of pulmonary blastomycosis in dogs: 125 cases (1989–2006). Journal of the American Veterinary Medical Association, 232(2), 222–227. https://doi.org/10.2460/javma.232.2.222
  • Legendre, A. M., Rohrbach, B. W., Toal, R. L., Rinaldi, M. G., Grace, L. L., & Jones, J. B. (1996). Treatment of blastomycosis with itraconazole in 112 dogs. Journal of Veterinary Internal Medicine, 10(6), 365–371. https://doi.org/10.1111/j.1939-1676.1996.tb02082.x
  • Walton, R. A. L., Wey, A., & Hall, K. E. (2017). A retrospective study of anti-inflammatory use in dogs with pulmonary blastomycosis: 139 cases (2002–2012). Journal of Veterinary Emergency and Critical Care, 27(4), 439–443. https://doi.org/10.1111/vec.12615
  • Kerl, M. E. (2003). Update on canine and feline fungal diseases. Veterinary Clinics of North America: Small Animal Practice, 33(4), 721–747. https://doi.org/10.1016/S0195-5616(03)00035-4
  • Krohne, S. G. (2000). Canine systemic fungal infections. Veterinary Clinics of North America: Small Animal Practice, 30(5), 1063–1090. https://doi.org/10.1016/S0195-5616(00)05007-5
  • Vieson, M. D., Piñeyro, P., & LeRoith, T. (2012). A review of the pathology and treatment of canine respiratory infections. Veterinary Medicine: Research and Reports, 3, 25–39. https://doi.org/10.2147/VMRR.S25021
  • García, M. E., Caro, A., Fragío, C., Blanco, I., & Blanco, J. L. (2001). A clinical case of canine mycotic pneumonia. Journal of Veterinary Medicine. Series A, Physiology, Pathology, Clinical Medicine, 48(8), 501–506. https://doi.org/10.1046/j.1439-0442.2001.00365.x